
Newamsterdam Pharma Co NV (NAMS)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy NAMS Stock
Start investing in NAMS
About Newamsterdam Pharma Co NV (NAMS)
Market cap | $2.27B |
Today's volume | 557.96K |
Revenue (TTM) | $47.14M |
Avg. daily volume | 906.13K |
EBITDA (TTM) | -$188.58M |
Open | $20.87 |
Price / earnings ratio | -10.76x |
Today's range | $20 - $21.91 |
Debt / equity | 0.05x |
52 week range | $14.06 - $27.29 |
5 year debt / equity | 0.05x |
Beta (LTM) | 0.92x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 19.98x |
Ex-dividend date | — |
Next earnings | Aug 6, 2025 |
Dividend payable date | — |
NAMS Stock Rating
NAMS Stock News
View all



Frequently Asked Questions (FAQ)
How to buy NAMS stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in NAMS stock
Navigate to the Explore page. Then, type NAMS into the search bar. When you see NAMS stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased NAMS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Newamsterdam Pharma Co NV Stock Earnings
The value each NAMS share was expected to gain vs. the value that each NAMS share actually gained.
NAMS (NAMS) reported Q1 2025 earnings per share (EPS) of -$0.34, beating estimates of -$0.44 by 22.73%. In the same quarter last year, NAMS's earnings per share (EPS) was $0. NAMS is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of $0.